Advancing genomic medicine: National Cancer Center Japan's role in personalized cancer treatment
Chinese Academy of SciencesIn a significant stride towards personalized cancer care, the National Cancer Center Japan (NCCJ) has marked a decade of progress in cancer genomic medicine (CGM). A comprehensive review outlines the evolution of CGM in Japan, highlighting the pivotal role of the NCCJ in this advancement. The study encapsulates the historical milestones, current achievements, and future directions in the field of CGM.